JG101
Posted - 03/21/24
$ATNM I presume many like me who owned both $ATNM and $FUSN and who made a killing on $FUSN are now doubling down into $ATNM. Also a bunch of people who knew little to nothing of RadioPharma are now fully awake after $PNT, $RYZB and now $FUSN were bought out for impressive premiums. At 200 million of market cap acquiring a sizeable position will need a lot of small shareholders to sell to the big fish. This company is extraordinarily cheap by any metric.
joka2189
Posted - 03/19/24
$PNT $RYZB $PSTV $FUSN $NBTX another one bites the dust. Bye Fusionđź‘‹
AAVIE
Posted - 02/21/24
@resume777 what happened to the $LLY and $PNT acquisition? cant read pickerbefores posts
resume777
Posted - 02/21/24
@Pickerbefore that's what happened with the $LLY and $PNT acquisition.
perchedcats
Posted - 02/12/24
$CATX seems that PB is best radioisotope - this was also confirmed when $PNT (just $LLY before BO was announced signed a strategic supply deal for PB… so $catx is leading with this tech… while most others are using Actinium
techj2022
Posted - 02/07/24
$FUSN relative strength vs xbi today. other radio pharmas $PNT $RYZB $CLRB $PSTV
JenineKeyt134
Posted - 01/30/24
$PNT Rising uranium markets are shedding light on STLNF's resource-rich projects.
popculture
Posted - 01/30/24
$PNT
VirginiaUber751
Posted - 01/22/24
$PNT Rising uranium markets are shedding light on STLNF's resource-rich projects.
knowthyself
Posted - 01/20/24
$LNTH $PNT Might not be the last word on PNT 2002. "Importantly, participants in the control arm could “cross over” to receive PNT2002 if their disease progressed. Some 84% of those who experienced progression ended up doing so, potentially confounding the study’s survival results. At the time of the analysis, survival results favored the control arm, but the picture could change as more data are accrued as the study continues. Point said additional results are expected next year. A similar pattern happened in Novartis’ study of Pluvicto, which showed treatment led to a median progression-free survival of 12 months, but no survival benefit. For Lilly, the SPLASH results may be beside the point.... Their interest in Point had equally as much to do with the company’s manufacturing and research capabilities. “Our interest in Point is a lot around the platform,” said Lilly’s CMO. “I think the time is right to get into therapeutic radiopharmaceuticals.”
knowthyself
Posted - 01/20/24
$LNTH $PNT Anyone have a good read on the PNT 2002 trial? Hit the primary endpoint, but came up short on the secondary--overall survival. In the press result, it said data was was not mature, only 49% of patients available. Any thoughts? Will OS improve? And if it doesn't, is the drug a dud? Has one hell of a TAM, if it is successful, in the billions.
ChartLaboratory_com
Posted - 01/19/24
$PNT testing vwap,> can be a monster heerover 4.70
CryptoAtlas
Posted - 01/18/24
$PGY $LCTX $MCRB $PNT Current spec positions...I don't consider STNE a spec anymore. It's a solid growth value play.
joka2189
Posted - 01/10/24
$PNT $RYZB very hot space surprise surprise as another one for solids gets absorbed. Not too many go-it alones left in the 'race'! Big $PSTV Plus Point! $FUSN or $NBTX likely next ones to go. Horses for courses.
Stock_Titan
Posted - 01/08/24
$PNT Domain Therapeutics Strengthens Leadership Team to Spearhead Global Development and North American Expansion as the Leading GPCR Immuno-Oncology Company
https://www.stocktitan.net/news/PNT/domain-therapeutics-strengthens-leadership-team-to-spearhead-global-r3um2u9wzpdk.html
UncleStock
Posted - 4 months ago
$SMLR $PNT $EGRX $VNDA suggested for Health Care - value screen: https://zpr.io/w3j8HS7Eft4n
tickeron
Posted - 12/31/23
If you are an active trader, pay attention! $PNT in -11.27% Downtrend, declining for three consecutive days on December 19, 2023. View odds for this and other indicators: https://srnk.us/go/4956163
UncleStock
Posted - 12/29/23
$PNT $EGRX $VNDA $INVA suggested for Pharmaceuticals and Biotechnology - value screen: https://zpr.io/NGP6QnBCdEbN
MWM
Posted - 12/28/23
$FUSN last man standing after $PNT and $RYZB?
josephfuller
Posted - 12/27/23
$PNT CATX People!. Their Pipe Is As Good As RAYZE Bio People!.
chunkynuts
Posted - 12/27/23
$PNT did this get bought out? And at what price
Ah121
Posted - 12/27/23
$PNT will the stock be up next year ?
Screaming_Eagle
Posted - 12/27/23
$PNT F you Ari. Hope you ch0ke on that money. Only reason why you're there was because of your uncle Allan S
Last10K
Posted - 12/27/23
$PNT just filed with the SEC a Ending Agreement, a Change in Assets, a Listing Status, a Security Holders Change, a Change in Control, a Event for Officers, a Bylaw Change and a Financial Exhibit https://last10k.com/sec-filings/PNT/0001193125-23-303512.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=PNT
risenhoover
Posted - 12/27/23
$PNT / POINT Biopharma Global files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 22, 2023 POINT BIOPHARMA https://fintel.io/doc/sec-point-biopharma-global-inc-1811764-8k-2023-december-27-19718-8776?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing
speakmannameonlyonce
Posted - 12/27/23
$BMY $RYZB $LLY $PNT $NVS $pnt